Ligand validation:2WIE

CVM: CYMAL-4

CVM is a Ligand Of Interest in 2WIE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
2WIE_CVM_B_108	27%	88%	0.129	0.922	0.34	0.33	-	-	0	18%	18.18
2WIE_CVM_E_106	27%	92%	0.156	0.949	0.36	0.17	-	-	0	18%	18.18
2WIE_CVM_B_104	27%	91%	0.122	0.913	0.35	0.23	-	-	0	18%	18.18
2WIE_CVM_A_106	22%	90%	0.157	0.917	0.35	0.25	-	-	0	18%	18.18
2WIE_CVM_E_103	22%	74%	0.165	0.925	0.36	0.63	-	-	0	18%	18.18
2WIE_CVM_D_107	20%	89%	0.138	0.888	0.37	0.26	-	-	0	18%	18.18
2WIE_CVM_C_106	18%	89%	0.183	0.918	0.37	0.26	-	-	0	18%	18.18
2WIE_CVM_D_106	17%	92%	0.132	0.859	0.34	0.21	-	-	0	18%	18.18
2WIE_CVM_C_103	17%	73%	0.149	0.871	0.33	0.68	-	-	0	18%	18.18
2WIE_CVM_A_103	14%	91%	0.176	0.874	0.31	0.28	-	-	1	18%	18.18
2WIE_CVM_B_107	11%	88%	0.227	0.895	0.36	0.31	-	-	0	18%	18.18
2WIE_CVM_A_107	8%	92%	0.319	0.944	0.34	0.21	-	-	0	18%	18.18
2WIE_CVM_D_109	8%	89%	0.146	0.756	0.36	0.27	-	-	1	18%	18.18
2WIE_CVM_D_104	7%	88%	0.3	0.902	0.36	0.3	-	-	0	18%	18.18
2WIE_CVM_E_109	6%	74%	0.243	0.833	0.36	0.64	-	-	0	18%	18.18
2WIE_CVM_C_107	6%	78%	0.292	0.883	0.34	0.53	-	-	1	18%	18.18
2WIE_CVM_A_110	6%	74%	0.287	0.871	0.34	0.64	-	-	0	18%	18.18
2WIE_CVM_B_109	6%	75%	0.246	0.828	0.32	0.64	-	-	0	18%	18.18
2WIE_CVM_E_107	6%	75%	0.322	0.905	0.34	0.62	-	-	0	18%	18.18
2WIE_CVM_A_109	6%	73%	0.253	0.832	0.37	0.64	-	-	0	18%	18.18
2WIE_CVM_B_103	5%	88%	0.218	0.779	0.34	0.34	-	-	0	18%	18.18
2WIE_CVM_D_108	5%	92%	0.301	0.861	0.36	0.19	-	-	0	18%	18.18
2WIE_CVM_A_104	5%	88%	0.325	0.871	0.34	0.32	-	-	1	18%	18.18
2WIE_CVM_B_110	4%	91%	0.356	0.89	0.34	0.23	-	-	0	18%	18.18
2WIE_CVM_B_106	4%	89%	0.275	0.805	0.36	0.28	-	-	0	18%	18.18
2WIE_CVM_C_109	4%	90%	0.275	0.804	0.33	0.28	-	-	0	18%	18.18
2WIE_CVM_D_103	4%	88%	0.279	0.801	0.34	0.34	-	-	1	18%	18.18
2WIE_CVM_E_104	3%	92%	0.327	0.831	0.35	0.19	-	-	1	18%	18.18
2WIE_CVM_C_110	3%	76%	0.398	0.89	0.34	0.58	-	-	0	18%	18.18
2WIE_CVM_C_108	2%	90%	0.401	0.849	0.34	0.27	-	-	1	18%	18.18
2WIE_CVM_D_110	2%	74%	0.454	0.892	0.32	0.66	-	-	1	18%	18.18
2WIE_CVM_A_108	2%	77%	0.405	0.83	0.35	0.56	-	-	0	18%	18.18
2WIE_CVM_C_104	2%	89%	0.356	0.763	0.35	0.29	-	-	0	18%	18.18
2WIE_CVM_B_102	1%	60%	0.347	0.535	0.38	1.1	-	3	4	100%	1
2WIE_CVM_E_108	1%	91%	0.462	0.771	0.39	0.2	-	-	0	18%	18.18
2WIE_CVM_E_110	1%	90%	0.602	0.889	0.33	0.28	-	-	0	18%	18.18
2WIE_CVM_A_102	1%	60%	0.386	0.452	0.41	1.07	-	3	4	100%	1
2WIE_CVM_C_102	1%	64%	0.367	0.43	0.49	0.86	-	-	9	100%	1
2WIE_CVM_D_102	0%	50%	0.365	0.322	0.47	1.43	-	7	5	100%	1
2WIE_CVM_E_102	0%	66%	0.42	0.267	0.42	0.87	-	1	2	100%	1
2XQU_CVM_C_103	38%	88%	0.082	0.931	0.37	0.29	-	-	0	18%	18.18
2XQS_CVM_E_106	15%	92%	0.265	0.972	0.39	0.16	-	-	1	18%	18.18
2XQT_CVM_C_1086	12%	75%	0.26	0.927	0.23	0.73	-	-	1	21%	0.2121
4IUU_CVM_B_302	17%	61%	0.238	0.814	0.46	0.99	-	3	2	100%	1
4IUR_CVM_A_302	15%	52%	0.225	0.848	0.46	1.37	-	7	0	67%	0.6667
4IUQ_CVM_B_302	15%	20%	0.274	0.836	1.23	2.33	5	20	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

2WIE

CVM: CYMAL-4

CVM is a Ligand Of Interest in 2WIE designated by the RCSB